Clinical Response to Olaparib in a Patient With Leptomeningeal Carcinomatosis in Newly Diagnosed Breast Cancer With Germline <i>BRCA2</i> Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Response to Olaparib in a Patient With Leptomeningeal Carcinomatosis in Newly Diagnosed Breast Cancer With Germline BRCA2 Mutation

Published:2024-07 Issue:8 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precis Oncol

Author:

Shah Manali¹^ORCID,Green Jeremy²,Hudacko Rachel³,Cohen Alice J.⁴

Affiliation:

1. Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ

2. Department of Radiology, Newark Beth Israel Medical Center, Newark, NJ

3. Department of Pathology, Newark Beth Israel Medical Center, Newark, NJ

4. Frederick B. Cohen Comprehensive Cancer & Blood Disorders Center, Newark Beth Israel Medical Center, Newark, NJ

Abstract

Case of LMC in a BRCA2-mutated breast cancer patient shows clinical improvement with Olaparib therapy

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.24.00063

Reference14 articles.

1. Breast cancer as a systemic disease: a view of metastasis

2. Breast Cancer

3. Leptomeningeal disease: current diagnostic and therapeutic strategies

4. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients

5. Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP